GE HealthCare

Empowering Personalized Breast Care

At GE HealthCare, we believe every patient’s journey is unique. That’s why we’re committed to advancing imaging technologies that help close the gap in diagnostic dilemmas leading to more confident treatment plans for patients. Our portfolio of diagnostic solutions supports patients at every step of their breast cancer journey. GE HealthCare is a proud contributor to Susan G. Komen’s educational initiatives, which provide resources and advocacy for those living with breast cancer. Our support reflects a shared commitment to improving outcomes through early detection, advanced imaging, and personalized care strategies.

Through our collaboration, we are determined to raise awareness around the importance of personalized diagnostics, especially for patients with estrogen receptor-positive (ER+) breast cancers, like invasive lobular carcinoma (ILC), that are difficult to detect on standard imaging tests.

GE HealthCare is dedicated to transforming the future of breast care for patients.

Patient Resources:

• Finding Joy in the Midst of a Metastatic Breast Cancer Diagnosis
• Seeing the Unseen: The Challenges of Detecting Lobular Breast Cancer
• Dispelling 4 Myths About PET Scans for Breast Cancer
• What to Know About Molecular Imaging
• Five Ways Nuclear Medicine Shapes Breast Cancer Care Through Real-World Scenarios

About GE HealthCare

GE HealthCare is a trusted global healthcare solutions partner, delivering advanced technologies, pharmaceutical diagnostics, and AI-powered tools that can help make hospitals more efficient, clinicians more effective, therapies more precise, and patients healthier and happier. With over 125 years of experience, we collaborate with providers worldwide to simplify care pathways and shape the future of personalized, connected, and compassionate care.

Follow us on LinkedIn,  Facebook, Instagram, and Insights for the latest news, or visit our website https://www.gehealthcare.com/ for more information. 

October 2025 | JB12545US